Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CA 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1931857A reveals a scalable permanganate oxidation route for Losartan 5-carboxylate (EXP-3174), offering high purity and eliminating chromatography for cost-effective API manufacturing.
Patent CN104311532B details a robust synthesis for Canagliflozin intermediates. Discover cost-effective, scalable manufacturing solutions for pharmaceutical supply chains.
Novel synthesis of catechol compounds via cyclohexanone and sulfone. High yield, scalable process for pharma and agrochemical intermediates.
Patent CN113061094A details a cost-effective H-D exchange route for Ractopamine-D6. Achieve >98% purity and >96% isotopic abundance for LC-MS food safety testing.
Patent CN108329249B introduces a scalable HMTA-based route for indole-3-carbaldehyde, offering superior purity and cost efficiency for pharmaceutical intermediate manufacturing.
Novel zinc-catalyzed cyclization route eliminates palladium, reducing costs and impurities for high-purity Tezacaftor intermediate manufacturing.
Patent CN114318375A reveals a green electrochemical route for Indolo[2,3-a]carbazole, offering high purity and cost reduction in electronic chemical manufacturing.
Novel patent CN104910195B enables efficient difluoromethylation. Stable solid reagent offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.
Patent CN101535274B details a novel reductive defluorination route for fungicide intermediates, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN101535274B reveals a cost-effective route for difluoromethyl pyrazole intermediates, enabling scalable fungicide production with reduced raw material costs.
Patent CN115703769A reveals a one-step ammonium carbonate cyclization for Azilsartan, offering high purity and reduced waste for pharmaceutical manufacturing.
Novel five-step route avoids hazardous HMPA and cryogenic conditions. Delivers high purity pharmaceutical intermediates with scalable industrial production capabilities.
Novel synthesis of (S)/(R)-midpacamide using chiral amino acids. Solves racemization, >99% purity. Reliable supply for pharma R&D.
Patent CN109293722B details a novel synthesis for Azithromycin Impurity P using modified platinum carbon catalysis, offering reliable supply for pharmaceutical quality control.
Advanced separation method for 5-chloro-2-hydroxy-4-methoxybenzophenone from sulfonation waste. High purity >99.5% for pharma intermediates.
Novel synthetic method for 5,6-dimethoxy-2-pyridine carboxylic acid offers simplified processing and high purity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN110790708A details a novel iridium-catalyzed asymmetric hydrogenation route for Eslicarbazepine intermediates, offering high enantioselectivity and atom economy for pharmaceutical manufacturing.
Novel hydrogenation-cyclization route offers high yield and mild conditions for scalable production of protected diazaspiro compounds.
Patent CN111187163A reveals a solvent-free Lewis acid catalyzed route for prohexadione calcium intermediates, offering high purity and scalable manufacturing for global agrochemical supply chains.
Patent CN109928926B details a novel Wittig-based synthesis for APS-5 key intermediate, offering streamlined production and cost reduction in chemiluminescent material manufacturing.